Measuring What Can't Be Seen: How PTSD Clinical Trials Prove a Drug Works
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a...
Posts about
Neurology/CNS
The Psychedelic Setback: What MDMA Rejection Taught Drug Developers
In August 2024, the FDA declined to approve MDMA-assisted therapy for post-traumatic stress...
What RAPS Convergence 2025 Means for Sponsors Preparing Global Submissions
It was wonderful to connect with so many of our peers at RAPS Convergence 2025 in Pittsburgh. As...
Why Regulatory Publishing Expertise is Essential for Neurology Clinical Trials
Developing treatments for neurological, psychiatric, or CNS disorders means navigating complex...